Efficacy of Trimetazidine Dihydrochloride for Relieving Chronic Tinnitus: A Randomized Double-Blind Study
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: To evaluate the efficacy of trimetazidine dihydrochloride as a treatment for chronic tinnitus. Methods: A total of 97 chronic tinnitus patients were evaluated in this randomized, prospective, double-blind, placebo-controlled trial. After assessing for eligibility, 82 patients were randomly assigned into placebo or trimetazidine groups according to the medication. The trimetazidine group received 20×3 mg/day per oral trimetazidine dihydrochloride and the placebo group received 20×3 mg/day per oral placebo for 3 months. Tinnitus handicap inventory (THI), visual analogue scale (VAS) questionnaires and audiometric results were used to determine the effectiveness of trimetazidine treatment. Results: The study group comprised 82 tinnitus subjects, 42 (51%) of whom received trimetazidine dihydrochloride and 40 (49%) who received placebo. There was no significant difference between placebo and trimetazidine groups in THI grade and VAS (both pre- and posttreatment scores) (P>0.05) and no significant improvement was observed in subjective loudness score in either group (P>0.05). Additionally there was no significant difference between groups in pre- and posttreatment pure tone hearing thresholds at all measured frequencies (P>0.05). Conclusion: Trimetazidine dihydrochloride therapy was ineffective for relieving chronic tinnitus.
Abstract
Objectives: To evaluate the efficacy of trimetazidine dihydrochloride as a treatment for chronic tinnitus. Methods: A total of 97 chronic tinnitus patients were evaluated in this randomized, prospective, double-blind, placebo-controlled trial. After assessing for eligibility, 82 patients were randomly assigned into placebo or trimetazidine groups according to the medication. The trimetazidine group received 20×3 mg/day per oral trimetazidine dihydrochloride and the placebo group received 20×3 mg/day per oral placebo for 3 months. Tinnitus handicap inventory (THI), visual analogue scale (VAS) questionnaires and audiometric results were used to determine the effectiveness of trimetazidine treatment. Results: The study group comprised 82 tinnitus subjects, 42 (51%) of whom received trimetazidine dihydrochloride and 40 (49%) who received placebo. There was no significant difference between placebo and trimetazidine groups in THI grade and VAS (both pre- and posttreatment scores) (P>0.05) and no significant improvement was observed in subjective loudness score in either group (P>0.05). Additionally there was no significant difference between groups in pre- and posttreatment pure tone hearing thresholds at all measured frequencies (P>0.05). Conclusion: Trimetazidine dihydrochloride therapy was ineffective for relieving chronic tinnitus.
참고문헌 (28)
- Jastreboff PJ, "Phantom auditory perception(tinnitus) : mechanisms of generation and perception", Neurosci Res, 8(4), pp.221~254 (1990)
- Coles RR, "Epidemiology of tinnitus : (1)prevalence", J Laryngol Otol Suppl, 9, pp.7~15 (1984)
- Mattox DE, "Assessment and management of tinnitus and hearing loss", Contin: Lifelong Learn Neurol, 12(4), pp.135~150 (2006)
- Konig O., "Course of hearing loss and occurrence of tinnitus", Hear Res, 221(1-2), pp.59~64 (2006)
- Dobie RA, "A review of randomized clinical trials in tinnitus", Laryngoscope, 109(8), pp.1202~1211 (1999)
- Morgon A, "A multicenter double blind versus placebo study of trimetazidine in tinnitus: results obtained after 2 months of treatment", Ann Otolaryngol Chir Cervicofac, 107(Suppl 1), pp.77~81 (1990)
- Martini A., "Trimetazidine versus betahistine in Ménière’s disease. a double blind method", Ann Otolaryngol Chir Cervicofac, 107(Suppl 1), pp.20~27 (1990)
- Peng S., "The efficacy of trimetazidine on stable angina pectoris : a meta-analysis of randomized clinical trials", Int J Cardiol, 177(3), pp.780~785 (2014)
- Kluyskens P., "Trimetazidine versus betahistine in vestibular vertigo. A double blind study", Ann Otolaryngol Chir Cervicofac, 107(Suppl 1), pp.11~19 (1990)
- Wayoff M., "Evaluation of the therapeutic efficacy of vastarel 20 mg (trimetazidine) in cochleovestibular syndromes. A double-blind study versus placebo", Ann Otolaryngol Chir Cervicofac, 101(7), pp.565~569 (1984)
- Newman CW., "Development of the tinnitus handicap inventory", Arch Otolaryngol Head Neck Surg, 122(2), pp.143~148 (1996)
- McCombe A., "Guidelines for the grading of tinnitus severity : the results of a working group commissioned by the British Association of Otolaryngologists, Head and Neck Surgeons, 1999", Clin Otolaryngol Allied Sci, 26(5), pp.388~393 (2001)
- Unal OF., "Prevention of gentamicin induced ototoxicity by trimetazidine in animal model", Int J Pediatr Otorhinolaryngol, 69(2), pp.193~199 (2005)
- Aksoy F., "Protective effect of trimetazidine on amikacin-induced ototoxicity in rats", Int J Pediatr Otorhinolaryngol, 78(4), pp.663~669 (2014)
- Kiani F., "Off-frequency listening in subjects with chronic tinnitus", Hear Res, 306, pp.1~10 (2013)
- Rah YC., "Successful treatment of sudden sensorineural hearing loss assures improvement of accompanying tinnitus", Laryngoscope, 125(6), pp.1433~1437 (2015)
- Langguth B., "Emerging pharmacotherapy of tinnitus", Expert Opin Emerg Drugs, 16(4), pp.603~606 (2011)
- Darlington CL., "Drug treatments for tinnitus", Prog Brain Res, 166, pp.249~262 (2007)
- Robinson SK., "Antidepressant therapy in tinnitus", Hear Res, 226(1-2), pp.221~231 (2007)
- Kalcioglu MT., "Objective evaluation of the effects of intravenous lidocaine on tinnitus", Hear Res, 199(1-2), pp.81~88 (2005)
- Simpson JJ., "Recent advances in the pharmacological treatment of tinnitus", Trends Pharmacol Sci, 20(1), pp.12~18 (1999)
- Aazh H., "Gabapentin for tinnitus : a systematic review", Am J Audiol, 20(2), pp.151~158 (2011)
- James AL., "Betahistine for Menière’s disease or syndrome", Cochrane Database Syst Rev, (1), pp.CD001873~ (2001)
- Hilton MP., "Ginkgo biloba for tinnitus", Cochrane Database Syst Rev, 3, pp.CD003852~ (2013)
- Ernst E., "Placebo: new insights into an old enigma", Drug Discov Today, 12(9-10), pp.413~418 (2007)
- Haguenauer JP., "Trimetazidine and degenerative deafness. Effect on hearing and integration", Ann Otolaryngol Chir Cervicofac, 107(Suppl 1), pp.51~56 (1990)
- Kim DK., "Prevalence and significance of high-frequency hearing loss in subjectively normal-hearing patients with tinnitus", Ann Otol Rhinol Laryngol, 120(8), pp.523~528 (2011)
- 심현준, "Hearing Abilities at Ultra-High Frequency in Patients with Tinnitus", Clinical and Experimental Otorhinolaryngology, 2(4), pp.169~174 (2009), 대한이비인후과학회